Giao dịch STAAR Surgical Co - STAA CFD

Điều kiện giao dịch

• Loại: CFD
• Chênh lệch: 0.11
• Điều chỉnh phí tài trợ qua đêm cho vị thế mua: -0.02157%
• Điều chỉnh phí tài trợ qua đêm cho vị thế bán: -0.00065%
• Thời gian điều chỉnh phí tài trợ qua đêm: 22:00 (UTC)
• Tiền tệ: USD
• Số lượng giao dịch tối thiểu: 1
• Biên lợi nhuận: 5.00%
• Sàn giao dịch chứng khoán: United States of America
• Phí hoa hồng giao dịch: 0%
• Bảo đảm dừng phí bảo hiểm: 1%

Số liệu thống kê chính

• Trước đó Đóng: 18.89
• Mở: 18.89
• Thay đổi 1 năm: -21.91%
• Phạm vi trong ngày: 18.66 - 18.95

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.